Charles River Laboratories International (CRL) Total Debt (2009 - 2025)

Charles River Laboratories International (CRL) has reported Total Debt for 17 consecutive years, with $2.1 billion the latest figure, recorded in Q4 2025.

• In Q4 2025, Total Debt fell 4.64% year-over-year to $2.1 billion; the TTM figure through Dec 2025 stood at $2.1 billion (down 4.64% YoY), while the FY2025 annual figure was $2.1 billion, down 4.64% from the prior year.
• Total Debt came in at $2.1 billion for Q4 2025 at Charles River Laboratories International, down from $2.2 billion in the prior quarter.
• The five-year high for Total Debt was $3.0 billion in Q2 2022, with the low at $2.1 billion in Q4 2025.
• Average Total Debt over 5 years is $2.6 billion, with a median of $2.7 billion recorded in 2023.
• Across the five-year window, Total Debt surged 34.68% in 2021 and decreased 15.37% in 2024, its largest moves.
• Year by year, Total Debt stood at $2.7 billion in 2021, then advanced by 1.54% to $2.7 billion in 2022, then retreated by 2.23% to $2.6 billion in 2023, then slipped by 15.37% to $2.2 billion in 2024, then fell by 4.64% to $2.1 billion in 2025.
• According to Business Quant data, Total Debt over the past three periods registered $2.1 billion, $2.2 billion, and $2.3 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.